Etidronate disodium

Generic Medicine Info
Overt osteomalacia; abnormalities of the oesophagus (e.g. stricture, achalasia) which may delay oesophagaeal emptying.
Special Precautions
Patient w/ enterocolitis. Renal impairment. Pregnancy and lactation. Patient Counselling Maintain adequate intake of Ca and vit D, good oral hygiene. Monitoring Parameters Monitor alkaline phosphatase and serum Ca levels. Perform routine dental check up.
Adverse Reactions
Paraesthesia, peripheral neuropathy, confusion, amnesia, depression, hallucination; bone/joint/muscle pain, bone fracture, GI irritation, osteonecrosis of the jaw. Rarely, burning sensation of tongue, alopecia, erythema multiforme, exacerbation of asthma, agranulocytosis or pancytopenia.
Drug Interactions
May increase prothrombin time w/ warfarin. May enhance the adverse effects of deferasirox. Decreased serum concentration w/ antacids, multivitamins/minerals. Increased hypocalcaemic effect w/ aminoglycosides. Increased adverse/toxic effect w/ NSAIDs, systemic angiogenesis inhibitors. Diminished therapeutic effect w/ PPIs.
ATC Classification
M05BA01 - etidronic acid ; Belongs to the class of bisphosphonates. Used in the treatment of bone diseases.
Disclaimer: This information is independently developed by CIMS based on etidronate disodium from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in